The FDA has approved a third respiratory syncytial virus vaccine for high-risk adults aged younger than 50 years — a ...

They aren't just "pandemic stocks." ...

Total revenues of €174.7 million in line with guidance, including €157.9 million in product sales Strong year-end cash position of €109.7 ...

The global nasal drug delivery technology market is projected to grow at a CAGR of approximately 7% over the next five years.

First tranche of $15 million expected to close on March 20, 2026; second tranche of up to $15 million available, for up to $30 million in total ...

A federal work group says Covid vaccine injuries deserve urgent attention, even as Health Secretary Robert F. Kennedy Jr.

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the randomized Phase 2 FOURLIGHT-1 study evaluating atirmociclib in combination with fulvestrant, versus fulvestrant or everolimus ...

A man used ChatGPT to cure his dog. Here are the stocks for the new age of programmable medicine. Pet owner Paul Conyngham (second right) and Professor Pall Thordarson discussed the cancer vaccine ...

(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

Both Bank of America and JPMorgan are hosting conferences on the industrial sector, featuring presentations from companies including Boeing (BA) and American Airlines (AAL). Delta Air Lines (DAL) ...

Health care and life sciences clients already make up a significant share of Sachs Media’s roster, with recent and current engagements including HCA Healthcare, Pfizer, the National Association of ...

If Americans hoped to get some clarity from Health Secretary Robert F. Kennedy Jr.’s vaccine panel on who should be getting a COVID-19 shot this fall, they may be disappointed. The Advisory Committee ...